Results 101 to 110 of about 11,556 (210)

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić   +4 more
wiley   +1 more source

Cost‐effectiveness of DPYD genotyping prior to fluoropyrimidine‐based treatment for colorectal cancer in Wales

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Background Regulatory guidance in the United Kingdom advises DPYD genotyping prior to fluoropyrimidine‐based treatment. This economic evaluation estimated the costs and outcomes associated with DPYD screening prior to prescribing fluoropyrimidines for colorectal cancer in Wales and also considers additional variants to those included in ...
Catrin O. Plumpton   +8 more
wiley   +1 more source

Trends in publicly subsidized and private access to GLP‐1 medicines indicated for type 2 diabetes in Australia, 2020–2025

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims GLP‐1 medicines provide substantial cardio‐renal benefits for type 2 diabetes (T2D) and are increasingly used for weight loss. Most high‐income countries subsidize access for T2D with restrictions; use outside of these restrictions occurs through private prescriptions. Despite strong consumer demand, the extent of private access to GLP‐1 medicines
Michael O. Falster   +10 more
wiley   +1 more source

GAVI supply chain strategy people and practice evidence review

open access: yesJournal of Pharmaceutical Policy and Practice, 2014
Pamela Steele
doaj   +1 more source

Characterizing Low Falling Number in the Absence of Elevated Alpha‐Amylase Activity in Soft White Wheat and the Impact on Japanese Sponge Cakes

open access: yesCereal Chemistry, EarlyView.
ABSTRACT Background and Objectives Non‐alpha‐amylase induced low falling number was identified in 2024 soft white wheat. The objectives of this work were to characterize these low falling number samples and determine the impact on end‐product quality. The results were analyzed to determine differences in flour characteristics that might result in a low
Gabriely M. Soncin Alfaro   +7 more
wiley   +1 more source

Reply

open access: yes
Arthritis &Rheumatology, EarlyView.
Joseph F. Merola   +6 more
wiley   +1 more source

From Surgical Innovation to Population Impact: Robot‐Assisted Radical Prostatectomy and the Evolution of Surgical Public Health in Brazil's Unified Health System

open access: yesChronic Diseases and Translational Medicine, EarlyView.
ABSTRACT Brazil's Unified Health System (Sistema Único de Saúde, SUS) represents one of the world's largest universal health systems and provides a unique real‐world platform for integrating prevention, diagnosis, treatment, and survivorship across the cancer continuum.
Leonardo Oliveira Reis
wiley   +1 more source

Internal Carbon Cycles in the Steel Industry: Pathways for CO2 Management and Carbon Capture Utilization

open access: yesChemie Ingenieur Technik, EarlyView.
The steel industry accounts for about 7%‐9% of global CO2 emissions. While H2‐based direct reduction is a long‐term route, near‐term solutions are needed for existing plants. Internal carbon cycles reuse steelworks off‐gases and by‐products, enabling circular carbon use and supporting CCU integration.
Florian Haakmann   +4 more
wiley   +1 more source

An Analytical Design Model of a Vacuum Pressure Swing Adsorption Process for Biogas Upgrading

open access: yesChemie Ingenieur Technik, EarlyView.
A steady‐state model was developed for a vacuum pressure swing adsorption (VPSA) process comprising adsorption, depressurization, and evacuation steps. The resulting analytical plant design model provides the optimal adsorber height required to achieve a target product purity with maximum bed utilization.
Thomas Welter   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy